BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines

Feline leukemia virus (FeLV) is a cosmopolitan gammaretrovirus that causes lifelong infections and fatal diseases, including leukemias, lymphomas, immunodeficiencies, and anemias, in domestic and wild felids. There is currently no definitive treatment for FeLV, and while existing vaccines reduce the...

Full description

Bibliographic Details
Main Authors: Garrick M. Moll, Cheryl L. Swenson, Vilma Yuzbasiyan-Gurkan
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/9/1853
_version_ 1797576396940247040
author Garrick M. Moll
Cheryl L. Swenson
Vilma Yuzbasiyan-Gurkan
author_facet Garrick M. Moll
Cheryl L. Swenson
Vilma Yuzbasiyan-Gurkan
author_sort Garrick M. Moll
collection DOAJ
description Feline leukemia virus (FeLV) is a cosmopolitan gammaretrovirus that causes lifelong infections and fatal diseases, including leukemias, lymphomas, immunodeficiencies, and anemias, in domestic and wild felids. There is currently no definitive treatment for FeLV, and while existing vaccines reduce the prevalence of progressive infections, they neither provide sterilizing immunity nor prevent regressive infections that result in viral reservoirs with the potential for reactivation, transmission, and the development of associated clinical diseases. Previous studies of murine leukemia virus (MuLV) established that host cell epigenetic reader bromodomain and extra-terminal domain (BET) proteins facilitate MuLV replication by promoting proviral integration. Here, we provide evidence that this facilitatory effect of BET proteins extends to FeLV. Treatment with the archetypal BET protein bromodomain inhibitor (+)-JQ1 and FeLV challenge of two phenotypically disparate feline cell lines, 81C fibroblasts and 3201 lymphoma cells, significantly reduced FeLV proviral load, total FeLV DNA load, and p27 capsid protein expression at nonlethal concentrations. Moreover, significant decreases in FeLV proviral integration were documented in 81C and 3201 cells. These findings elucidate the importance of BET proteins for efficient FeLV replication, including proviral integration, and provide a potential target for treating FeLV infections.
first_indexed 2024-03-10T21:51:32Z
format Article
id doaj.art-75297dddc5aa41e59acdc9556eb7e2e3
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T21:51:32Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-75297dddc5aa41e59acdc9556eb7e2e32023-11-19T13:22:38ZengMDPI AGViruses1999-49152023-08-01159185310.3390/v15091853BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell LinesGarrick M. Moll0Cheryl L. Swenson1Vilma Yuzbasiyan-Gurkan2Comparative Medicine & Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USAComparative Medicine & Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USAComparative Medicine & Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USAFeline leukemia virus (FeLV) is a cosmopolitan gammaretrovirus that causes lifelong infections and fatal diseases, including leukemias, lymphomas, immunodeficiencies, and anemias, in domestic and wild felids. There is currently no definitive treatment for FeLV, and while existing vaccines reduce the prevalence of progressive infections, they neither provide sterilizing immunity nor prevent regressive infections that result in viral reservoirs with the potential for reactivation, transmission, and the development of associated clinical diseases. Previous studies of murine leukemia virus (MuLV) established that host cell epigenetic reader bromodomain and extra-terminal domain (BET) proteins facilitate MuLV replication by promoting proviral integration. Here, we provide evidence that this facilitatory effect of BET proteins extends to FeLV. Treatment with the archetypal BET protein bromodomain inhibitor (+)-JQ1 and FeLV challenge of two phenotypically disparate feline cell lines, 81C fibroblasts and 3201 lymphoma cells, significantly reduced FeLV proviral load, total FeLV DNA load, and p27 capsid protein expression at nonlethal concentrations. Moreover, significant decreases in FeLV proviral integration were documented in 81C and 3201 cells. These findings elucidate the importance of BET proteins for efficient FeLV replication, including proviral integration, and provide a potential target for treating FeLV infections.https://www.mdpi.com/1999-4915/15/9/1853feline leukemia virusretrovirusgammaretrovirusesprovirusviral loadintegration
spellingShingle Garrick M. Moll
Cheryl L. Swenson
Vilma Yuzbasiyan-Gurkan
BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines
Viruses
feline leukemia virus
retrovirus
gammaretroviruses
provirus
viral load
integration
title BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines
title_full BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines
title_fullStr BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines
title_full_unstemmed BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines
title_short BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines
title_sort bet inhibitor jq1 attenuates feline leukemia virus dna provirus and antigen production in domestic cat cell lines
topic feline leukemia virus
retrovirus
gammaretroviruses
provirus
viral load
integration
url https://www.mdpi.com/1999-4915/15/9/1853
work_keys_str_mv AT garrickmmoll betinhibitorjq1attenuatesfelineleukemiavirusdnaprovirusandantigenproductionindomesticcatcelllines
AT cheryllswenson betinhibitorjq1attenuatesfelineleukemiavirusdnaprovirusandantigenproductionindomesticcatcelllines
AT vilmayuzbasiyangurkan betinhibitorjq1attenuatesfelineleukemiavirusdnaprovirusandantigenproductionindomesticcatcelllines